Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Cobbold

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2024
Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal CancersAllison M Barrett, Zachary T Britton, Rosa A Carrasco, et al.
The Journal of Clinical Investigation|November 17, 2015
Inflammation drives thrombosis after Salmonella infection via CLEC-2 on plateletsJessica R Hitchcock, Charlotte N Cook, Saeeda Bobat, et al.
Science (New York, N.Y.)|April 24, 2010
Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adultsCalman A MacLennan, James J Gilchrist, Melita A Gordon, et al.
Nature Biotechnology|February 12, 2020
Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapyDavid G Millar, Rakesh R Ramjiawan, Kosuke Kawaguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2021
Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with CancerAyumi Hashimoto, Debashis Sarker, Vikash Reebye, et al.
The Journal of Clinical Investigation|November 15, 2023
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancerPeter Zanvit, Dewald van Dyk, Christine Fazenbaker, et al.
Nature Communications|February 24, 2024
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironmentElizabeth L Hardaker, Emilio Sanseviero, Ankur Karmokar, et al.
Plos Biology|July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyMariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2024
Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal CancersAllison M Barrett, Zachary T Britton, Rosa A Carrasco, et al.
The Journal of Clinical Investigation|November 17, 2015
Inflammation drives thrombosis after Salmonella infection via CLEC-2 on plateletsJessica R Hitchcock, Charlotte N Cook, Saeeda Bobat, et al.
Science (New York, N.Y.)|April 24, 2010
Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adultsCalman A MacLennan, James J Gilchrist, Melita A Gordon, et al.
Nature Biotechnology|February 12, 2020
Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapyDavid G Millar, Rakesh R Ramjiawan, Kosuke Kawaguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2021
Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with CancerAyumi Hashimoto, Debashis Sarker, Vikash Reebye, et al.
The Journal of Clinical Investigation|November 15, 2023
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancerPeter Zanvit, Dewald van Dyk, Christine Fazenbaker, et al.
Nature Communications|February 24, 2024
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironmentElizabeth L Hardaker, Emilio Sanseviero, Ankur Karmokar, et al.
Plos Biology|July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyMariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
Pageof 6